(Q35967042)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15570827%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

review article

1 reference

title

Immunological aspects of head and neck cancer: biology, pathophysiology and therapeutic mechanisms (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15570827%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

1 reference

1 reference

head and neck carcinoma

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15570827%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

R A Robins

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15570827%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

O Eremin

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15570827%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

publication date

1 August 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15570827%20AND%20SRC:MED&resulttype=core&format=json

Journal of the Royal College of Surgeons of Edinburgh

5 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15570827%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15570827%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15570827%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

187-207

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15570827%20AND%20SRC:MED&resulttype=core&format=json

Estimates of the worldwide incidence of 25 major cancers in 1990.

5 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Patterns of cervical node metastases from squamous carcinoma of the oropharynx and hypopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

The patterns of cervical lymph node metastases from squamous carcinoma of the oral cavity

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Targeting epidermal growth factor receptor: novel therapeutics in the management of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Current role of gene therapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Biology of natural killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Natural cytotoxicity uncoupled from the Syk and ZAP-70 intracellular kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Receptors for HLA class-I molecules in human natural killer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

A class I antigen, HLA-G, expressed in human trophoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Roles of the NKG2D immunoreceptor and its ligands

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Rescue of the colony-stimulating factor 1 (CSF-1)-nullizygous mouse (Csf1(op)/Csf1(op)) phenotype with a CSF-1 transgene and identification of sites of local CSF-1 synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Mature monocytic cells enter tissues and engraft

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Adhesion molecules and inflammatory injury.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

The inflammatory macrophage: a story of Jekyll and Hyde

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Fibronectin activates murine peritoneal macrophages for tumor cell destruction in the presence of IFN-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Tumor-infiltrating macrophages induce apoptosis in activated CD8(+) T cells by a mechanism requiring cell contact and mediated by both the cell-associated form of TNF and nitric oxide.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Characterization of matrix metalloproteinases produced by rat alveolar macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Mechanisms of phagocytosis in macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Chronic immune activation and inflammation in the pathogenesis of AIDS and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Chronic immune activation and inflammation as the cause of malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

1 reference

7 January 2021

Interleukin-12 p40 secretion by cutaneous CD11c+ and F4/80+ cells is a major feature of the innate immune response in mice that develop Th1-mediated protective immunity to Schistosoma mansoni

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

IL-12 is required to maintain a Th1 response during Leishmania major infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Naturally arising CD25+CD4+ regulatory T cells in maintaining immunologic self-tolerance and preventing autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Some interfaces of dendritic cell biology

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Dendritic cells capable of stimulating T cells in germinal centres

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Costimulatory regulation of T cell function.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

MHC antigens and tumor escape from immune surveillance

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

The dendritic cell system and its role in immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. I. Rejection by syngeneic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. T lymphocyte-mediated cytolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. IV. Analysis of variant-specific antigens by selection of antigen-loss variants with cytolytic T cell clones

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. III. Clonal analysis of the syngeneic cytolytic T lymphocyte response

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

The immunological synapse: a molecular machine controlling T cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Clinical implications of biomarkers in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Prevalence of Epstein-Barr virus in oral squamous cell carcinoma, oral lichen planus, and normal oral mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Human cortactin as putative cancer antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM-3 is selectively exposed in a range of primary carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

An innate sense of danger

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Beyond self and nonself: fuzzy recognition of the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

The danger model: a renewed sense of self

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Replicative senescence and cell immortality: the role of telomeres and telomerase

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Extension of life-span by introduction of telomerase into normal human cells

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT)

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Evolving views of telomerase and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Mutations of the beta2-microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Alterations of HLA class I and II antigen expression in preinvasive, invasive and metastatic cervical cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Antitumor immunity at work in a melanoma patient

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

HLA-G expression in human melanoma cells: protection from NK cytolysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Soluble Fas-ligand (sFasL) in human astrocytoma cyst fluid is cytotoxic to T-cells: another potential means of immune evasion

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Apoptosis in the immune system: 1. Fas-induced apoptosis in monocytes-derived human dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Colorectal cancer cells induce lymphocyte apoptosis by an endothelial monocyte-activating polypeptide-II-dependent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Endothelial monocyte-activating polypeptide-II (EMAP-II): a novel inducer of lymphocyte apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Transforming growth factor beta1 (TGFbeta1) expression in head and neck squamous cell carcinoma patients as related to prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Transforming growth factor beta1, urokinase-type plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in head and neck squamous carcinoma and normal adjacent mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Dysregulated expression of MIC-1/PDF in human prostate tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Macrophage Inhibitory Cytokine-1 in Gestational Tissues and Maternal Serum in Normal and Pre-eclamptic Pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Elevated serum levels of transforming growth factor-beta1 in patients with colorectal carcinoma: its association with tumor progression and its significant decrease after curative surgical resection

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Profile of gene expression regulated by induced p53: connection to the TGF-beta family

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

The B7 and CD28 receptor families

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

CD28/B7 system of T cell costimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Can Co‐stimulated Tumor Immunity be Therapeutically Efficacious?

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Co-expression of B7-1 and ICAM-1 on tumors is required for rejection and the establishment of a memory response.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Adhesion to target cells is disrupted by the killer cell inhibitory receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Contribution of serum inhibitory factors and immune cellular defects to the depressed cell-mediated immunity in patients with head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Expansion of natural killer cells in patients with head and neck cancer: detection of "noninhibitory" (activating) killer Ig-like receptors on circulating natural killer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Preferential apoptosis of CD56dim natural killer cell subset in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Dysfunctional regulation of the development of monocyte-derived dendritic cells in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Expression profiles of angiogenic growth factors in squamous cell carcinomas of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Coley's toxins, tumor necrosis factor and cancer research: a historical perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Intravesical bacille Calmette-Guérin versus mitomycin C in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Vaccination of cancer patients against telomerase induces functional antitumor CD8+ T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

The first 1000 dendritic cell vaccinees.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

A phase I study of autologous dendritic cell-based immunotherapy for patients with unresectable primary liver cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

A pilot trial of tumor lysate-loaded dendritic cells for the treatment of metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Dendritic cell (DC) based therapy for cervical cancer: use of DC pulsed with tumour lysate and matured with a novel synthetic clinically non-toxic double stranded RNA analogue poly [I]:poly [C(12)U] (Ampligen R).

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Vaccination with autologous tumour antigen-pulsed dendritic cells in advanced gynaecological malignancies: clinical and immunological evaluation of a phase I trial

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Effectiveness of systemic BCG therapy in advanced melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Cancer immunotherapy: the past, the present and the future

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

BCG (Bacillus of Calmette Guerin) therapy of high-risk superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Intravesical bacillus Calmette-Guérin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

BCG in perspective: advances in the treatment of superficial bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

A Randomized Trial of Adjuvant BCG Immunotherapy in Head and Neck Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Multidisciplinary treatment of head and neck cancer using BCG, OK-432, and GE-132 as biologic response modifiers

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Generation of vaccine-primed lymphocytes for the treatment of head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Thymosin alpha(1) in combination with cytokines and chemotherapy for the treatment of cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Modulatory role of thymosin-alpha-1 in normal bone-marrow haematopoiesis and its effect on myelosuppression in T-cell lymphoma bearing mice

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Thymosin alpha 1 exerts protective effect against the 5-FU induced bone marrow toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Thymic hormones in cancer diagnostics and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Sequential chemoimmunotherapy for advanced non-small cell lung cancer using cisplatin, etoposide, thymosin-alpha 1 and interferon-alpha 2a

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Suppression of cellular immunity by head and neck irradiation. Precipitating factors and reparative mechanisms in an experimental model

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

In vitro immune modulation by thymosin alpha 1 in patients with head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

A trial of IRX-2 in patients with squamous cell carcinomas of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Effect of oral levamisole supplementation to hepatitis B vaccination on the rate of immune response in chronic hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Experimental modulation of IL-1 production and cell surface molecule expression by levamisole

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Levamisole induces interleukin-18 and shifts type 1/type 2 cytokine balance

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Levamisole effects on major histocompatibility complex and adhesion molecule expression and on myeloid cell adhesion to human colon tumor cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Adjuvant Trial of Levamisole in Patients With Squamous Cancer of the Head and Neck: A Preliminary Report

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Sequential induction chemotherapy and concomitant chemoradiotherapy in the management of locoregionally advanced laryngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Long-term survival following induction chemoradiotherapy and esophagectomy for esophageal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Interleukin 12 gene therapy of cancer by peritumoral injection of transduced autologous fibroblasts: outcome of a phase I study

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Phase I trial of concurrent twice-weekly recombinant human interleukin-12 plus low-dose IL-2 in patients with melanoma or renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

The role of interleukin-2 in combination adenovirus gene therapy for head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Combination nonviral cytokine gene therapy for head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Regression of tumor growth and induction of long-term antitumor memory by interleukin 12 electro-gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Transfer of interleukin 2 receptor genes into squamous cell carcinoma. Modification of tumor cell growth.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Advancing role of radiolabeled antibodies in the therapy of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

An anti-CD30 single-chain Fv selected by phage display and fused to Pseudomonas exotoxin A (Ki-4(scFv)-ETA') is a potent immunotoxin against a Hodgkin-derived cell line

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Antitumor effect of an HER2-specific antibody-toxin fusion protein on human prostate cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Recombinant antibody toxins specific for ErbB2 and EGF receptor inhibit the in vitro growth of human head and neck cancer cells and cause rapid tumor regression in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Target cell-induced T cell activation with bi- and trispecific antibody fragments

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Clinical experience with CD64-directed immunotherapy. An overview

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Role of immunotherapy in stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Immunotherapy with effector cells and IL-2 of lymph node metastases of human squamous-cell carcinoma of the head and neck established in nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Systemic adoptive T-cell immunotherapy in recurrent and metastatic carcinoma of the head and neck: a phase 1 study

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Peptide-pulsed splenic dendritic cells prime long-lasting CD8(+) T cell memory in the absence of cross-priming by host APC.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Dendritic cells are dysfunctional in patients with operable breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Proliferating dendritic cell progenitors in human blood

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Granulocyte-macrophage colony stimulating factor induces both HLA-DR expression and cytokine production by human monocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Granulocyte/macrophage-colony stimulating factor and interleukin-4 expand and activate type-1 dendritic cells (DC1) when administered in vivo to cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Effects of granulocyte-macrophage colony stimulating factor (GM-CSF) in vivo on cytokine production and proliferation by spleen cells

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Dendritic cells differentiated from human monocytes through a combination of IL-4, GM-CSF and IFN-gamma exhibit phenotype and function of blood dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

IFN-alpha enhances CD40 ligand-mediated activation of immature monocyte-derived dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Interferon-alpha disables dendritic cell precursors: dendritic cells derived from interferon-alpha-treated monocytes are defective in maturation and T-cell stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

IL-13 can substitute for IL-4 in the generation of dendritic cells for the induction of cytotoxic T lymphocytes and gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Tolerogenic dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Immunogenicity and therapeutic efficacy of dendritic-tumor hybrid cells generated by electrofusion

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

Telomerase pulsed dendritic cells for immunotherapy for renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2804%2980001-5

7 January 2021

10.1016/S1479-666X(04)80001-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15570827%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference